Eliot Forster

Insider Reports History

Entity
Individual
Location
C/O Eddeva B920, Babraham Research Campus, Cambridge, United Kingdom
Signature
/s/ Eyal Rubin, POA
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eliot Forster:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. Director Stock Options (Right to Buy) 85.7K Sep 14, 2023 Direct
F-star Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 0 $7.12 Mar 8, 2023 Direct
F-star Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 0 Mar 8, 2023 Direct

Insider Reports Filed by Eliot Forster

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLX Protalix BioTherapeutics, Inc. Sep 14, 2023 1 $0 4 Sep 15, 2023 Director
PLX Protalix BioTherapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 15, 2023 Director
FSTX F-star Therapeutics, Inc. Mar 8, 2023 5 -$3M 4 Mar 9, 2023 PRESIDENT AND CEO, Director
FSTX F-star Therapeutics, Inc. Jul 29, 2022 3 $28.7K 4 Aug 2, 2022 President and CEO, Director
FSTX F-star Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 President and CEO, Director
FSTX F-star Therapeutics, Inc. Jan 9, 2022 1 $0 4 Jan 11, 2022 President and CEO, Director